Back to search
Hemodialysis Subjects With Secondary Hyperparathyroidism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hemodialysis Subjects With Secondary Hyperparathyroidism trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hemodialysis Subjects With Secondary Hyperparathyroidism trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.
This is a multi-center, open, single-arm phase IIb clinical study comprising 2 parts, which Part A will enroll about 110 subjects, and Part B will enroll about…
MT1013 is a first-in-class dual-target agonist.This study is being conducted to determine the mass balance and routes of excretion of total radioactivity after…
This is a randomized, positive controlled, and placebo-controlled phase II clinical study to evaluate the efficacy and safety of MT1013 injection in the treatme…